Log in

Strongbridge Biopharma SEC Filings & 10K Form (NASDAQ:SBBP)

$1.84
+0.01 (+0.55 %)
(As of 12/15/2019 04:00 PM ET)
Today's Range
$1.81
Now: $1.84
$1.88
50-Day Range
$1.46
MA: $1.81
$2.46
52-Week Range
$1.43
Now: $1.84
$5.69
Volume240,430 shs
Average Volume327,023 shs
Market Capitalization$99.75 million
P/E Ratio5.94
Dividend YieldN/A
Beta0.71

SEC Filings

Strongbridge Biopharma (NASDAQ:SBBP) SEC Filings

DateFilerForm TypeView
11/19/2019
7:30 AM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2019
4:33 PM
JOHNSON JOHN (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
4:19 PM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2019
6:43 AM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2019
7:12 AM
Strongbridge Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2019
6:42 AM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2019
5:33 AM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2019
7:48 AM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2019
6:52 AM
Strongbridge Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2019
6:38 AM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2019
7:00 AM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2019
3:49 PM
Strongbridge Biopharma (Issuer)
Wilhoit Scott L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:48 PM
Strongbridge Biopharma (Issuer)
Wilhoit Scott L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/16/2019
3:15 PM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2019
7:01 AM
Strongbridge Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2019
6:45 AM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2019
6:39 AM
Strongbridge Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/12/2019
6:30 AM
Strongbridge Biopharma (Filer)
Form DEF 14A
03/11/2019
6:42 AM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2019
6:45 AM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2019
6:43 AM
Strongbridge Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2019
6:45 AM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2019
7:51 AM
Cohen Fredric J. (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2019
7:50 AM
DAVIS A BRIAN (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2019
7:50 AM
LONG STEPHEN J (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2019
7:50 AM
Pauls Matthew (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
2:40 PM
Strongbridge Biopharma (Subject)
Vivo Capital VIII, LLC (Filed by)
Form SC 13G/A
02/14/2019
1:21 PM
ARMISTICE CAPITAL, LLC (Filed by)
Strongbridge Biopharma (Subject)
Form SC 13G/A
02/12/2019
4:13 PM
Longitude Capital Partners III, LLC (Filed by)
Strongbridge Biopharma (Subject)
Form SC 13G/A
02/01/2019
3:17 PM
HealthCap VI, L.P. (Filed by)
Strongbridge Biopharma (Subject)
Form SC 13G/A
12/28/2018
4:39 PM
CAXTON CORP (Reporting)
CDK ASSOCIATES, L.L.C. (Reporting)
Kovner Bruce (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2018
3:42 PM
Capital Royalty L.P. (Filed by)
Strongbridge Biopharma (Subject)
Form SC 13G
12/21/2018
5:16 PM
CAXTON CORP (Reporting)
CDK ASSOCIATES, L.L.C. (Reporting)
Kovner Bruce (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
8:56 AM
NOVO NORDISK A S (Filed by)
Strongbridge Biopharma (Subject)
Form SC 13G
12/19/2018
7:16 AM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2018
3:44 PM
Cohen Fredric J. (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2018
6:09 AM
Longitude Capital Partners III, LLC (Filed by)
Strongbridge Biopharma (Subject)
Form SC 13G
10/31/2018
4:08 PM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2018
3:08 PM
Strongbridge Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2018
8:02 AM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2018
7:00 AM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2018
1:30 PM
Strongbridge Biopharma (Filer)
Form CT ORDER
08/28/2018
6:45 AM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2018
3:06 PM
CAXTON CORP (Filed by)
Strongbridge Biopharma (Subject)
Form SC 13D/A
08/15/2018
7:52 PM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2018
7:39 PM
Strongbridge Biopharma (Filer)
Form 424B5
08/09/2018
11:28 AM
CAXTON CORP (Reporting)
CDK ASSOCIATES, L.L.C. (Reporting)
Kovner Bruce (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2018
6:01 AM
Strongbridge Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2018
6:00 AM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2018
3:56 PM
CAXTON CORP (Reporting)
CDK ASSOCIATES, L.L.C. (Reporting)
Kovner Bruce (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/27/2018
5:15 PM
CAXTON CORP (Reporting)
CDK ASSOCIATES, L.L.C. (Reporting)
Kovner Bruce (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2018
2:37 PM
Cohen Fredric J. (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2018
4:33 PM
CAXTON CORP (Reporting)
CDK ASSOCIATES, L.L.C. (Reporting)
Kovner Bruce (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2018
12:55 PM
CAXTON CORP (Reporting)
CDK ASSOCIATES, L.L.C. (Reporting)
Kovner Bruce (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2018
3:30 PM
Opaleye Management Inc. (Filed by)
Strongbridge Biopharma (Subject)
Form SC 13G
06/11/2018
6:45 AM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2018
7:42 AM
Steineger Hilde H (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
7:41 AM
Steen Marten (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
7:41 AM
SHERMAN JEFFREY W (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
7:40 AM
Kong Garheng (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
7:40 AM
Kollender Richard S (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
7:40 AM
JOHNSON JOHN (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
7:00 AM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2018
6:56 AM
Strongbridge Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2018
6:49 AM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2018
7:00 AM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2018
7:00 AM
Strongbridge Biopharma (Filer)
Form DEF 14A
03/27/2018
11:15 PM
Strongbridge Biopharma (Filer)
Form EFFECT
03/27/2018
11:15 PM
Strongbridge Biopharma (Filer)
Form EFFECT
03/27/2018
8:28 AM
Strongbridge Biopharma (Filer)
Form CT ORDER
03/22/2018
3:07 PM
Strongbridge Biopharma (Filer)
Form S-3/A
03/15/2018
11:15 PM
Strongbridge Biopharma (Filer)
Form EFFECT
03/15/2018
11:15 PM
Strongbridge Biopharma (Filer)
Form EFFECT
03/12/2018
7:18 AM
Strongbridge Biopharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/12/2018
7:14 AM
Strongbridge Biopharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/12/2018
7:07 AM
Strongbridge Biopharma (Filer)
Form POS AM
03/12/2018
7:06 AM
Strongbridge Biopharma (Filer)
Form POS AM
03/12/2018
7:01 AM
Strongbridge Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2018
6:45 AM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2018
1:37 PM
LONG STEPHEN J (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2018
1:37 PM
Pauls Matthew (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2018
1:37 PM
Cohen Fredric J. (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2018
1:37 PM
DAVIS A BRIAN (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2018
4:09 PM
RA CAPITAL MANAGEMENT, LLC (Filed by)
Strongbridge Biopharma (Subject)
Form SC 13G/A
02/14/2018
9:58 AM
ARMISTICE CAPITAL, LLC (Filed by)
Strongbridge Biopharma (Subject)
Form SC 13G/A
02/06/2018
3:59 PM
Pauls Matthew (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2018
3:58 PM
Cohen Fredric J. (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2018
3:58 PM
DAVIS A BRIAN (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2018
3:58 PM
LONG STEPHEN J (Reporting)
Strongbridge Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2018
3:49 PM
Strongbridge Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/30/2018
3:30 PM
HealthCap VI, L.P. (Filed by)
Strongbridge Biopharma (Subject)
Form SC 13G/A
01/26/2018
4:03 PM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/26/2018
3:10 PM
Strongbridge Biopharma (Filer)
Form 424B5
01/23/2018
4:28 PM
Strongbridge Biopharma (Filer)
Form 424B5
01/17/2018
8:44 PM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2018
6:15 AM
Strongbridge Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2018
3:56 PM
Strongbridge Biopharma (Issuer)
Viswanathan Ravi (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/09/2018
3:55 PM
Sonsini Peter W. (Reporting)
Strongbridge Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/09/2018
3:55 PM
SANDELL SCOTT D (Reporting)
Strongbridge Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/09/2018
3:54 PM
MOTT DAVID M (Reporting)
Strongbridge Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
This page was last updated on 12/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel